CD276 and glioblastoma: As B7H3-IL7R-S exhibited superior antitumor activity compared with that of other intrinsic IL7Rα constructs, we tested the antitumor effects of B7H3-IL7R-S in comparison with those of conventional B7H3 CAR-T cells in xenograft models of glioblastoma.